Rheumatic Heart Disease
ICD-10 I01 · ICD-11 1B41

Rheumatic Heart Disease in Mixed Mitral Valve Disease — Mitral Regurgitation and Mitral Stenosis

When rheumatic heart disease causes both mitral regurgitation and mitral stenosis simultaneously, the resulting mixed mitral valve disease presents a narrow therapeutic window. The coexistence of both lesions restricts which pharmacological approaches can be safely applied.

Clinical Scenario

This protocol is specific to rheumatic heart disease presenting as mixed mitral valve disease — the simultaneous presence of mitral regurgitation and mitral stenosis. This combination significantly limits the medical treatment options compared to either lesion managed in isolation.

Treatment Approach

In this scenario, medical therapy options are considerably constrained. Diuretic agents play a central role — and in mixed mitral valve disease specifically, they may represent the only available pharmacological intervention. The full structured regimen outlines the appropriate approach within this limitation.

Instant Access to Structured Evidence-Based Regimens

References

Conversely, in mixed mitral valve disease, diuretic agents may be the only medical therapy available.

DOI: 10.1161/CIR.0000000000000921

View source ↗